Martin TJ - Search Results

1

Murine models of osteosarcoma: A piece of the translational puzzle.

Walia MK, Castillo-Tandazo W, Mutsaers AJ, Martin TJ, Walkley CR. Walia MK, et al. Among authors: martin tj. J Cell Biochem. 2018 Jun;119(6):4241-4250. doi: 10.1002/jcb.26601. Epub 2018 Feb 27. J Cell Biochem. 2018. PMID: 29236321 Review.

2

Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.

Mutsaers AJ, Ng AJ, Baker EK, Russell MR, Chalk AM, Wall M, Liddicoat BJ, Ho PW, Slavin JL, Goradia A, Martin TJ, Purton LE, Dickins RA, Walkley CR. Mutsaers AJ, et al. Among authors: martin tj. Bone. 2013 Jul;55(1):166-78. doi: 10.1016/j.bone.2013.02.016. Epub 2013 Feb 26. Bone. 2013. PMID: 23486187

3

The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.

Ng AJ, Walia MK, Smeets MF, Mutsaers AJ, Sims NA, Purton LE, Walsh NC, Martin TJ, Walkley CR. Ng AJ, et al. Among authors: martin tj. PLoS Genet. 2015 Apr 10;11(4):e1005160. doi: 10.1371/journal.pgen.1005160. eCollection 2015 Apr. PLoS Genet. 2015. PMID: 25859855 Free PMC article.

4

Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.

Walia MK, Ho PM, Taylor S, Ng AJ, Gupte A, Chalk AM, Zannettino AC, Martin TJ, Walkley CR. Walia MK, et al. Among authors: martin tj. Elife. 2016 Apr 12;5:e13446. doi: 10.7554/eLife.13446. Elife. 2016. PMID: 27070462 Free PMC article.

5

PTHrP, its receptor, and protein kinase A activation in osteosarcoma.

Walkley CR, Walia MK, Ho PW, Martin TJ. Walkley CR, et al. Among authors: martin tj. Mol Cell Oncol. 2014 Dec 31;1(4):e965624. doi: 10.4161/23723548.2014.965624. eCollection 2014 Oct-Dec. Mol Cell Oncol. 2014. PMID: 27308361 Free PMC article.

6

Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53.

Walia MK, Taylor S, Ho PWM, Martin TJ, Walkley CR. Walia MK, et al. Among authors: martin tj. Cell Death Dis. 2018 Aug 28;9(9):844. doi: 10.1038/s41419-018-0944-8. Cell Death Dis. 2018. PMID: 30154459 Free PMC article.

7

Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death.

Bhattacharya S, Chalk AM, Ng AJ, Martin TJ, Zannettino AC, Purton LE, Lu J, Baker EK, Walkley CR. Bhattacharya S, et al. Among authors: martin tj. Oncogene. 2016 Oct 6;35(40):5282-5294. doi: 10.1038/onc.2016.68. Epub 2016 Apr 4. Oncogene. 2016. PMID: 27041566

8

Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.

Baker EK, Taylor S, Gupte A, Chalk AM, Bhattacharya S, Green AC, Martin TJ, Strbenac D, Robinson MD, Purton LE, Walkley CR. Baker EK, et al. Among authors: martin tj. Bone. 2015 Apr;73:223-32. doi: 10.1016/j.bone.2014.12.063. Epub 2015 Jan 5. Bone. 2015. PMID: 25571841 Free article.

9

Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Ho PW, Goradia A, Russell MR, Chalk AM, Milley KM, Baker EK, Danks JA, Slavin JL, Walia M, Crimeen-Irwin B, Dickins RA, Martin TJ, Walkley CR. Ho PW, et al. Among authors: martin tj. Oncogene. 2015 May 28;34(22):2922-33. doi: 10.1038/onc.2014.217. Epub 2014 Jul 21. Oncogene. 2015. PMID: 25043296

10

RARγ is a negative regulator of osteoclastogenesis.

Green AC, Poulton IJ, Vrahnas C, Häusler KD, Walkley CR, Wu JY, Martin TJ, Gillespie MT, Chandraratna RA, Quinn JM, Sims NA, Purton LE. Green AC, et al. Among authors: martin tj. J Steroid Biochem Mol Biol. 2015 Jun;150:46-53. doi: 10.1016/j.jsbmb.2015.03.005. Epub 2015 Mar 20. J Steroid Biochem Mol Biol. 2015. PMID: 25800721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

850 results

Search Page